BioSpace News Archive

60 Degrees Pharma as submitted a NDA to the FDA for the use of Tafenoquine to prevent malaria in adults traveling to areas where malaria is prevalent.

In the pre-specified secondary endpoints, GC4419 demonstrated a consistent effect across all efficacy measures.

SciFluor announced positive top-line results of a Phase 1/2 trial studying the treatment of ‘wet’ age-related macular degeneration (AMD) patients with SF0166, the company’s lead eye drop drug for back of the eye diseases.

Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a two-year, $165,000 grant from the NIH to understand how young women who completed cancer treatment make fertility decisions and plan for future family-building.

Repros today announced that following an Oral Explanation, it has received feedback that a negative opinion is likely to be received in January 2018 from the CHMP for the centralized MAA for enclomiphene for the treatment of secondary hypogonadism previously submitted to the EMA by the Company’s U.K. subsidiary, Renable Pharma Limited.

Following up on Mr. Steel’s resignation, the number of Board of Director seats has been reduced to five.

This designation may provide, under specified conditions, for a seven-year marketing exclusivity period, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees.

Deciphera Pharma today announced that it has been added to the Russell 2000® Index, as part of Russell’s quarterly IPO additions, effective Friday, December 15, 2017, after market close.

Regeneron and ISA Pharma today announced a clinical collaboration to advance ISA101 in combination with cemiplimaba, a PD-1 antibody.

A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.